| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/11/2001 | US6287601 Equine laminitis |
| 09/11/2001 | US6287600 Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin |
| 09/11/2001 | US6287599 Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles |
| 09/11/2001 | US6287598 Method for providing sustained antiepileptic therapy |
| 09/11/2001 | US6287597 Antihistaminic/decongestant compositions |
| 09/11/2001 | US6287596 Drug delivery |
| 09/11/2001 | US6287595 Biomedical assay device |
| 09/11/2001 | US6287594 Oral liquid compositions |
| 09/11/2001 | US6287593 Anticancer |
| 09/11/2001 | US6287592 Aqueous drink composition comprising ibuprofen |
| 09/11/2001 | US6287591 Stable for theraputic use, hiv, cytomegalo virus, antiinflammatory, antitumor |
| 09/11/2001 | US6287590 Peptide/lipid complex formation by co-lyophilization |
| 09/11/2001 | US6287588 Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof |
| 09/11/2001 | US6287587 Forming a water in oil emulsion comprising a solution containing a water-soluble 2-piprazinone-1-acetic acid derivative and arganine as intergrin antagonist, a solvent, abiodegradable polymer, and fat and oil, removing the solvent |
| 09/11/2001 | US6287576 Biostimulating agent |
| 09/11/2001 | US6287558 Devices containing cells or tissue and an agent that inhibits damage by a host cell molecule |
| 09/11/2001 | US6287551 Method for treating herpes virus |
| 09/11/2001 | US6287541 Oral care compositions |
| 09/11/2001 | US6287540 Therapeutic dry powder |
| 09/11/2001 | US6287341 Mixing a reactive amorphous calcium phosphate, a second calcium phosphate that has a calcium to phosphate ratio of >or =1.67, and a physiological liquid in the amount to provide a paste or putty; introducing into an implant site |
| 09/11/2001 | US6287295 Osmotic delivery system, osmotic delivery system semimpermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems |
| 09/11/2001 | US6287294 Medical devices using electrosensitive gels |
| 09/11/2001 | US6287293 Method and apparatus for locating the injection point of an implanted medical device |
| 09/11/2001 | US6287249 Thin film radiation source |
| 09/11/2001 | CA2195119C Formulations and methods for providing prolonged local anesthesia |
| 09/11/2001 | CA2186382C Method and apparatus for diagnosing erectile dysfunction |
| 09/11/2001 | CA2072933C Mechanically-stable, readily-disintegratable tablets made of small preformed particles containing active ingredients |
| 09/10/2001 | CA2339705A1 Inhibiting oxidative degradation of pharmaceutical formulations |
| 09/07/2001 | WO2001064930A1 Protein hollow nano particles, transporter with the use of the same and method of introducing substance into cells |
| 09/07/2001 | WO2001064707A1 Melanoma differentiation associated gene - 5 and promoter and uses thereof |
| 09/07/2001 | WO2001064524A2 Metered dose inhaler |
| 09/07/2001 | WO2001064421A1 Method and apparatus for blowmoding capsules of polyvinylalcohol and blowmolded polyvinylalcohol capsules |
| 09/07/2001 | WO2001064344A2 Microfabricated devices for the storage and selective exposure of chemicals and devices |
| 09/07/2001 | WO2001064331A1 Method for producing micro and/or nanocapsules |
| 09/07/2001 | WO2001064330A1 Nanocapsules having a polyelectrolyte envelope |
| 09/07/2001 | WO2001064329A1 Microcapsule, in particular, for immobilizing organic or inorganic solids, liquids and/or gases |
| 09/07/2001 | WO2001064328A1 Lipid nanocapsules, preparation method and use as medicine |
| 09/07/2001 | WO2001064275A1 Metered dose inhaler |
| 09/07/2001 | WO2001064274A2 Metered dose inhaler |
| 09/07/2001 | WO2001064273A2 Metered dose inhaler |
| 09/07/2001 | WO2001064254A2 Engineered spray-dried lipid-based microparticles for cellular targeting |
| 09/07/2001 | WO2001064253A1 P-glycoprotein modifier-containing medicinal compositions to be delivered to the large intestine |
| 09/07/2001 | WO2001064245A1 Immune enhancement compositions and use thereof |
| 09/07/2001 | WO2001064241A1 Preparations stabilized over long time |
| 09/07/2001 | WO2001064232A1 Use of avocado-soybean unsaponifiable preparations |
| 09/07/2001 | WO2001064222A1 Veterinary compositions for the treatment of parasitic diseases |
| 09/07/2001 | WO2001064221A1 Low dose entecavir formulation and use |
| 09/07/2001 | WO2001064215A1 Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis |
| 09/07/2001 | WO2001064214A2 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors |
| 09/07/2001 | WO2001064202A2 Tramadol for the treatment of functional gastrointestinal disorders |
| 09/07/2001 | WO2001064191A1 Bodies for the controlled release of active substances |
| 09/07/2001 | WO2001064190A1 Rapidly disintegrable tablet containing polyvinyl alcohol |
| 09/07/2001 | WO2001064189A1 Coated granules and foaming compositions containing the same |
| 09/07/2001 | WO2001064188A1 Therapeutic compositions for pulmonary delivery |
| 09/07/2001 | WO2001064187A2 Anaesthetic formulations |
| 09/07/2001 | WO2001064186A1 Urogenital or anorectal transmucosal vaccine delivery system |
| 09/07/2001 | WO2001064185A2 Method for making, loading and sealing a cell or drug encapsulation device, and such a device |
| 09/07/2001 | WO2001064184A1 Percutaneous administration preparations |
| 09/07/2001 | WO2001064183A1 Orally administered controlled delivery system for once daily administration of ciprofloxacin |
| 09/07/2001 | WO2001064182A2 Improvements in or relating to the delivery of oral drugs |
| 09/07/2001 | WO2001064167A1 Cosmetic and pharmaceutical preparations for treating cellulite |
| 09/07/2001 | WO2001064164A2 Nanocapsule encapsulation system and method |
| 09/07/2001 | WO2001064163A2 An improved herbal composition having antiallergic properties and a process for the preparation thereof |
| 09/07/2001 | WO2001064151A1 Methods and apparatus for controlled heat to regulate transdermal delivery of medical substances |
| 09/07/2001 | WO2001064150A1 Transdermal patch comprising controlled heating device |
| 09/07/2001 | WO2001064149A1 Improved transdermal drug patch |
| 09/07/2001 | WO2001064148A1 Topically applied clotting material |
| 09/07/2001 | WO2001064046A2 Method for isolating sponge collagen and producing nanoparticulate collagen, and the use thereof |
| 09/07/2001 | WO2001064034A1 Antimicrobial sanitizing lotion with skin protection properties |
| 09/07/2001 | WO2001043747A8 Matrix tablet for prolonged release of trimetazidine after oral administration |
| 09/07/2001 | WO2001034115A3 Method for encapsulating proteins or peptides in liposomes, liposomes produced using said method, and their use |
| 09/07/2001 | WO2001013901A3 A pharmaceutical delivery system for vitamin c and vitamin e and use of a combination of vitamin c and e for preventing or treating conditions involving oxidative stress |
| 09/07/2001 | WO2001010408A3 Aqueous pharmaceutical composition containing moxifloxacin or salts thereof |
| 09/07/2001 | WO2000054763A3 Pharmaceutical compositions comprising polymorphic forms of dehydroepiandrosterone |
| 09/07/2001 | WO2000050004A3 Surgical anesthesia delivery system |
| 09/07/2001 | WO2000047203A9 Formulation and system for intra-oral delivery of pharmaceutical agents |
| 09/07/2001 | CA2401804A1 Urogenital or anorectal transmucosal vaccine delivery system |
| 09/07/2001 | CA2401741A1 Melanoma differentiation associated gene - 5 and promoter and uses thereof |
| 09/07/2001 | CA2401696A1 Therapeutic compositions for pulmonary delivery |
| 09/07/2001 | CA2401689A1 Microcapsule, in particular, for immobilizing organic or inorganic solids, liquids and/or gases |
| 09/07/2001 | CA2401596A1 Method and apparatus for blowmoulding capsules of polyvinylalcohol and blowmoulded polyvinylalcohol capsules |
| 09/07/2001 | CA2401352A1 Immune enhancement compositions and use thereof |
| 09/07/2001 | CA2401340A1 Compositions and methods for the treatment of inflammatory disease using topoisomerase inhibitors |
| 09/07/2001 | CA2401288A1 Improvements in or relating to the delivery of oral drugs |
| 09/07/2001 | CA2400950A1 Orally administered controlled delivery system for once daily administration of ciprofloxacin |
| 09/07/2001 | CA2374585A1 Antimicrobial sanitizing lotion with skin protection properties |
| 09/06/2001 | US20010020147 Delivery of oral drugs |
| 09/06/2001 | US20010020039 Controlled release formulation of divalproex sodium |
| 09/06/2001 | US20010020032 Olanzapine |
| 09/06/2001 | US20010020029 New multidose vial formulations for administering endo-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1-methyl-1H- indazole-3-carboxamide hydrochloride |
| 09/06/2001 | US20010020025 Mixture of antiserotonine compound with laxative; therapy for constipation |
| 09/06/2001 | US20010020016 Formulation |
| 09/06/2001 | US20010020013 Polymerase inhibitors |
| 09/06/2001 | US20010020011 Gene encapsulated in polymer; sustained release |
| 09/06/2001 | US20010019841 Medium and matrix for long-term proliferation of cells |
| 09/06/2001 | US20010019763 Aspect ration is from 2.7 to 4.5 and preferably from 3.0 to 4.4 |
| 09/06/2001 | US20010019725 High speed mixing of drug and carrier |
| 09/06/2001 | US20010019724 Carotenoid formulations, comprising a mixture of beta-carotene, lycopene and lutein |
| 09/06/2001 | US20010019721 Liquid composition |
| 09/06/2001 | US20010019719 Intravesical drug delivery system |